Azathioprine and Incision site haemorrhage - a phase IV clinical study of FDA data
Summary:
We study 58,922 people who have side effects when taking Azathioprine. Incision site haemorrhage is found, especially among people who are male, 50-59 old, also take Humira and have Ankylosing spondylitis.
The phase IV clinical study analyzes which people take Azathioprine and have Incision site haemorrhage. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
58,922 people reported to have side effects when taking Azathioprine.
Among them, 4 people (0.01%) have Incision site haemorrhage.
What is Azathioprine?
Azathioprine has active ingredients of azathioprine sodium. It is used in crohn's disease. Currently, eHealthMe is studying from 60,132 Azathioprine users.
What is Incision site haemorrhage?
Incision site haemorrhage (bleeding from incision site) is found to be associated with 620 drugs and 304 conditions by eHealthMe. Currently, we are studying 1,085 people who have Incision site haemorrhage.
Number of Azathioprine and Incision site haemorrhage reports submitted per year:

Gender of people who have Incision site haemorrhage when taking Azathioprine *:
- female: 0.0 %
- male: 100 %
Age of people who have Incision site haemorrhage when taking Azathioprine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 50 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 0.0 %
Common drugs people take besides Azathioprine *:
- Humira: 3 people, 75.00%
- Insulin: 2 people, 50.00%
- Zocor: 1 person, 25.00%
- Tylenol: 1 person, 25.00%
- Remicade: 1 person, 25.00%
- Questran: 1 person, 25.00%
- Prednisone: 1 person, 25.00%
- Folic Acid: 1 person, 25.00%
- Celebrex: 1 person, 25.00%
- Acetylsalicylic Acid: 1 person, 25.00%
Common side effects people have besides Incision site haemorrhage *:
- Weight Decreased: 4 people, 100.00%
- Heart Rate Increased: 2 people, 50.00%
- Pain: 2 people, 50.00%
- Prostatomegaly (enlargement of the prostate): 2 people, 50.00%
- Wound: 1 person, 25.00%
- Incision Site Pain: 1 person, 25.00%
- High Blood Pressure: 1 person, 25.00%
- Hepatic Steatosis (fatty liver disease): 1 person, 25.00%
- Haemorrhoids (a swollen vein or group of veins in the region of the anus): 1 person, 25.00%
- Granuloma (a small area of inflammation due to tissue injury): 1 person, 25.00%
Common conditions people have *:
- High Blood Pressure: 2 people, 50.00%
- Diabetes: 2 people, 50.00%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 50.00%
- Stable Angina (a constant chest pain): 1 person, 25.00%
- Colitis (inflammation of colon): 1 person, 25.00%
* Approximation only. Some reports may have incomplete information.
Do you take Azathioprine and have Incision site haemorrhage?
Check whether Incision site haemorrhage is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Azathioprine side effects by duration, gender and age:
- Azathioprine side effects (60,132 reports)
Incision site haemorrhage treatments and more:
- Incision site haemorrhage (1,085 reports)
Common drugs associated with Incision site haemorrhage:
All the drugs that are associated with Incision site haemorrhage:
- Incision site haemorrhage (620 drugs)
All the conditions that are associated with Incision site haemorrhage:
- Incision site haemorrhage (304 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on azathioprine sodium (the active ingredients of Azathioprine) and Azathioprine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tagamet and Swallowing Difficulty - 44 seconds ago
- Acai and Nausea - 2 minutes ago
- Potassium and Jaundice Cholestatic - 2 minutes ago
- Albuterol Sulfate and Costochondritis - 3 minutes ago
- Vincristine Sulfate and Zofran drug interaction - 3 minutes ago
- Chantix and Lidoderm drug interaction - 4 minutes ago
- Combigan and Clonazepam drug interaction - 4 minutes ago
- Haloperidol and Weight Decreased - 5 minutes ago
- Cranberry and Calcium drug interaction - 5 minutes ago
- Tagamet and Dysphagia Aggravated - 5 minutes ago